Angiotensin-(1–7) in kidney disease: a review of the controversies

Angiotensin-(1–7) attenuates high glucose-induced proximal tubular epithelial-to-mesenchymal transition via inhibiting ERK1/2 and p38 phosphorylation

(2012) Li Zhou et al.   LIFE SCIENCES

Telmisartan attenuates oxidative stress and renal fibrosis in streptozotocin induced diabetic mice with the alteration of angiotensin-(1–7)masreceptor expression associated with its PPAR-γ agonist action

(2011) Arun Prasath Lakshmanan et al.   FREE RADICAL RESEARCH

Angiotensin-Converting Enzyme 2 Deficiency Is Associated With Impaired Gestational Weight Gain and Fetal Growth Restriction

(2011) Manish S. Bharadwaj et al.   HYPERTENSION

Angiotensin (1-7) Induces Mas Receptor Internalization

(2011) Mariela M. Gironacci et al.   HYPERTENSION

Angiotensin-(1-7) Blockade Attenuates Captopril- or Hydralazine-induced Cardiovascular Protection in Spontaneously Hypertensive Rats Treated With NG-nitro-l-Arginine Methyl Ester

(2011) Ibrahim F Benter et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Cellular pathophysiology of ischemic acute kidney injury

(2011) Joseph V. Bonventre et al.   JOURNAL OF CLINICAL INVESTIGATION

Toxicological and Toxicokinetic Analysis of Angiotensin (1–7) in Two Species

(2011) Nicholas M. Mordwinkin et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Kidney regeneration and resident stem cells

(2011) Scott Reule et al.   Organogenesis

ACE2–angiotensin-(1–7)–Mas axis in renal ischaemia/reperfusion injury in rats

(2010) Kátia D. da Silveira et al.   CLINICAL SCIENCE

Angiotensin-(1–7) infusion is associated with increased blood pressure and adverse cardiac remodelling in rats with subtotal nephrectomy

(2010) Elena Velkoska et al.   CLINICAL SCIENCE

Angiotensin-converting enzyme 2 is a key modulator of the renin–angiotensin system in cardiovascular and renal disease

(2010) Chris Tikellis et al.   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

ACE2: more of Ang-(1–7) or less Ang II?

(2010) Carlos M Ferrario   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Angiotensin-(1–7) prevents diabetes-induced attenuation in PPAR-γ and catalase activities

(2010) Gursev S. Dhaunsi et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Loss of ACE2 accelerates time-dependent glomerular and tubulointerstitial damage in streptozotocin-induced diabetic mice

(2010) Atsushi Shiota et al.   HYPERTENSION RESEARCH

Impairment of the angiotensin-converting enzyme 2–angiotensin-(1-7)-Mas axis contributes to the acceleration of two-kidney, one-clip Goldblatt hypertension

(2010) Marcela Bürgelová et al.   JOURNAL OF HYPERTENSION

Urocanic acid as an efficient hydroxyl radical scavenger: a quantum theoretical study

(2010) Saumya Tiwari et al.   JOURNAL OF MOLECULAR MODELING

Increased ACE and Decreased ACE2 Expression in Kidneys from Patients with IgA Nephropathy

(2010) Sonoo Mizuiri et al.   NEPHRON CLINICAL PRACTICE

Angiotensin II and angiotensin-(1-7) decrease sFlt1 release in normal but not preeclamptic chorionic villi: an in vitro study

(2010) Lauren Anton et al.   Reproductive Biology and Endocrinology

Human Recombinant ACE2 Reduces the Progression of Diabetic Nephropathy

(2009) G. Y. Oudit et al.   DIABETES

Angiotensin-(1-7) stimulates hematopoietic progenitor cells in vitro and in vivo

(2009) S. Heringer-Walther et al.   HAEMATOLOGICA

Angiotensin (1−7) prevent heart dysfunction and left ventricular remodeling caused by renal dysfunction in 5/6 nephrectomy mice

(2009) Yiwen Li et al.   HYPERTENSION RESEARCH

Genetic deletion of the angiotensin-(1–7) receptor Mas leads to glomerular hyperfiltration and microalbuminuria

(2009) Sérgio V.B. Pinheiro et al.   KIDNEY INTERNATIONAL

Angiotensin-(1-7) activates a tyrosine phosphatase and inhibits glucose-induced signalling in proximal tubular cells

(2009) E. Gava et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Inhibition of the Renin-Angiotensin System in Chronic Kidney Disease: A Critical Look to Single and Dual Blockade

(2009) Francesco Locatelli et al.   NEPHRON CLINICAL PRACTICE

Angiotensin-(1–7) and the G Protein-Coupled Receptor Mas Are Key Players in Renal Inflammation

(2009) Vanesa Esteban et al.   PLoS One

Chronic angiotensin (17) injection accelerates STZ-induced diabetic renal injury1

(2008) Ying SHAO et al.   ACTA PHARMACOLOGICA SINICA

Expression of ACE and ACE2 in Individuals With Diabetic Kidney Disease and Healthy Controls

(2008) Sonoo Mizuiri et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Sex differences in circulating and renal angiotensins of hypertensive mRen().Lewis but not normotensive Lewis rats

(2008) Karl D. Pendergrass et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Angiotensin-(1-7) as an antihypertensive, antifibrotic target

(2008) Michael J. Katovich et al.   CURRENT HYPERTENSION REPORTS

ACE2 Deficiency Modifies Renoprotection Afforded by ACE Inhibition in Experimental Diabetes

(2008) C. Tikellis et al.   DIABETES

The angiotensin-(1–7) receptor agonist AVE0991 is cardioprotective in diabetic rats

(2008) Linda Ebermann et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

The angiotensin receptor type 1-Gqprotein-phosphatidyl inositol phospholipase Cβ-protein kinase C pathway is involved in activation of proximal tubule Na+-ATPase activity by angiotensin(1-7) in pig kidneys

(2008) Lucienne S. Lara et al.   EXPERIMENTAL PHYSIOLOGY

Role of angiotensin-converting enzyme 2 and angiotensin(1-7) in 17β-oestradiol regulation of renal pathology in renal wrap hypertension in rats

(2008) Hong Ji et al.   EXPERIMENTAL PHYSIOLOGY

Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease

(2008) Heather N. Reich et al.   KIDNEY INTERNATIONAL

The Two Stage Model of Preeclampsia: Variations on the Theme

(2008) J.M. Roberts et al.   PLACENTA

Genetically altered animal models for Mas and angiotensin-(1-7)

(2007) Natalia Alenina et al.   EXPERIMENTAL PHYSIOLOGY